Skip to main content
Top
Published in: Drugs & Aging 2/2016

01-02-2016 | Short Communication

A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study

Authors: Luca Pasina, Alessandra Marengoni, Simona Ghibelli, Flavio Suardi, Codjo D. Djade, Alessandro Nobili, Carlotta Franchi, Gianbattista Guerrini

Published in: Drugs & Aging | Issue 2/2016

Login to get access

Abstract

Background

Older nursing home residents often have a large number of diseases and frequently require multiple medications; the high consumption of psychotropic drugs is of particular concern. The majority of residents in nursing homes suffer from dementia, and the use of psychotropic drugs in these patients is very high. Prescription for short periods of time only are usually recommended to avoid the risk of adverse drug reactions and potentially severe drug–drug interactions (DDIs).

Objectives

The aim of this multicenter, prospective study was to optimize the prescription of psychotropic drugs, according to the Beers recommendations, in a sample of older patients living in nursing homes in Italy, through a multicomponent intervention, education of general practitioners, and the use of INTERcheck.

Methods

The study was run in ten nursing homes in Northern Italy from September 2013 to May 2014 (9 months), with the voluntary participation of 14 general practitioners. Each physician was asked to enroll at least 20 consecutive unselected patients. Three educational interventions (‘ex cathedra’ presentations) were organized by the researchers involved in the project, and a fourth training session was also held on the use of INTERCheck, a Computerized Prescription Support System (CPSS) developed to optimize drug prescription for older people with multimorbidity. Drug prescription information and sociodemographic characteristics of each patient were collected at three different time points—before the educational and training sessions (T0), after 5 months (T1), and after 9 months (T2).

Results

Among the 272 patients included in the analysis, a significant reduction was observed in the mean number of drugs, and in the percentage receiving psychotropic drugs and potentially inappropriate psychotropic drugs (11.5 and 30.6 %, respectively; p < 0.0001). Patients exposed to at least one potentially severe DDI also decreased from 145 (53.3 %) at the first time point to 87 (32.0 %) at the last time point (p < 0.0001). Results were confirmed in the 181 patients for whom information regarding drug treatment was available at all time points.

Conclusions

The combination of an educational intervention and the CPSS can achieve a significant reduction in potentially inappropriate psychotropic drug use, psychotropic duplicates, and potentially severe DDIs in nursing homes.
Literature
1.
go back to reference Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;8:63–72.CrossRefPubMed Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;8:63–72.CrossRefPubMed
2.
go back to reference Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–21.CrossRefPubMed Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–21.CrossRefPubMed
3.
go back to reference Ruggiero C, Dell’Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58.CrossRefPubMed Ruggiero C, Dell’Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58.CrossRefPubMed
4.
go back to reference Selbæk G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:843–9.CrossRefPubMed Selbæk G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:843–9.CrossRefPubMed
5.
go back to reference Eggermont LH, de Vries K, Scherder EJ. Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. Int Psychogeriatr. 2009;21(2):286–94.CrossRefPubMed Eggermont LH, de Vries K, Scherder EJ. Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. Int Psychogeriatr. 2009;21(2):286–94.CrossRefPubMed
6.
go back to reference Wetzels RB, Zuidema SU, de Jonghe JF, et al. Prescribing pattern of psychotropic drugs in nursing home residents with dementia. Int Psychogeriatr. 2011;23(8):1249–59.CrossRefPubMed Wetzels RB, Zuidema SU, de Jonghe JF, et al. Prescribing pattern of psychotropic drugs in nursing home residents with dementia. Int Psychogeriatr. 2011;23(8):1249–59.CrossRefPubMed
7.
go back to reference Nijk RM, Zuidema SU, Koopmans RT. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr. 2009;21(3):485–93.CrossRefPubMed Nijk RM, Zuidema SU, Koopmans RT. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr. 2009;21(3):485–93.CrossRefPubMed
8.
go back to reference Ballard CG, Gauthier S, Cummings JL, Brodaty H, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.CrossRefPubMed Ballard CG, Gauthier S, Cummings JL, Brodaty H, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.CrossRefPubMed
9.
go back to reference Ballard C, Corbett A, Chitramohan R, et al. Management of agitation and aggression associated with Alzheimer’s disease: controversies and possible solutions. Curr Opin Psychiatry. 2009;22(6):532–40.CrossRefPubMed Ballard C, Corbett A, Chitramohan R, et al. Management of agitation and aggression associated with Alzheimer’s disease: controversies and possible solutions. Curr Opin Psychiatry. 2009;22(6):532–40.CrossRefPubMed
10.
go back to reference Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.CrossRefPubMed Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.CrossRefPubMed
11.
go back to reference Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348:g1996.PubMedCentralCrossRefPubMed Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348:g1996.PubMedCentralCrossRefPubMed
12.
13.
go back to reference Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol. 2009;8(2):151–7.CrossRefPubMed Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol. 2009;8(2):151–7.CrossRefPubMed
14.
go back to reference Gareri P, De Fazio P, Manfredi VG, et al. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol. 2014;34(1):109–23.CrossRefPubMed Gareri P, De Fazio P, Manfredi VG, et al. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol. 2014;34(1):109–23.CrossRefPubMed
15.
go back to reference Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021–31.CrossRefPubMed Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021–31.CrossRefPubMed
16.
go back to reference van der Cammen TJM, Rajkumar C, Onder G, et al. Drug cessation in complex older adults: time for action. Age Ageing. 2014;43(1):20–5.CrossRefPubMed van der Cammen TJM, Rajkumar C, Onder G, et al. Drug cessation in complex older adults: time for action. Age Ageing. 2014;43(1):20–5.CrossRefPubMed
17.
go back to reference Declercq T, Petrovic M, Azermai M, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;3:CD007726.PubMed Declercq T, Petrovic M, Azermai M, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;3:CD007726.PubMed
18.
go back to reference Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging. 2010;27(12):947–57.CrossRefPubMed Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging. 2010;27(12):947–57.CrossRefPubMed
19.
go back to reference van Dijk KN, de Vries CS, van den Berg PB, et al. Drug utilization in Dutch nursing homes. Eur J Clin Pharmacol. 2000;55(10):765–71.CrossRefPubMed van Dijk KN, de Vries CS, van den Berg PB, et al. Drug utilization in Dutch nursing homes. Eur J Clin Pharmacol. 2000;55(10):765–71.CrossRefPubMed
20.
go back to reference Smeets CH, Smalbrugge M, Gerritsen DL, et al. Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial. BMC Psychiatry. 2013;13:280.PubMedCentralCrossRefPubMed Smeets CH, Smalbrugge M, Gerritsen DL, et al. Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial. BMC Psychiatry. 2013;13:280.PubMedCentralCrossRefPubMed
21.
go back to reference Aspinall SL, Zhao X, Semla TP, et al. Epidemiology of drug-disease interactions in older veteran nursing home residents. J Am Geriatr Soc. 2015;63(1):77–84.PubMedCentralCrossRefPubMed Aspinall SL, Zhao X, Semla TP, et al. Epidemiology of drug-disease interactions in older veteran nursing home residents. J Am Geriatr Soc. 2015;63(1):77–84.PubMedCentralCrossRefPubMed
22.
go back to reference O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.CrossRefPubMed O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.CrossRefPubMed
23.
go back to reference Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck®). Drugs Aging. 2013;30(10):821–8.CrossRefPubMed Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck®). Drugs Aging. 2013;30(10):821–8.CrossRefPubMed
24.
go back to reference Buostani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef Buostani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20.CrossRef
25.
go back to reference Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.CrossRefPubMed Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.CrossRefPubMed
26.
go back to reference Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;(10):CD00816. Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;(10):CD00816.
27.
go back to reference Verrue CL, Petrovic M, Mehuys E, et al. Pharmacists’ interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging. 2009;26(1):37–49.CrossRefPubMed Verrue CL, Petrovic M, Mehuys E, et al. Pharmacists’ interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging. 2009;26(1):37–49.CrossRefPubMed
28.
go back to reference Forsetlund L, Eike MC, Gjerberg E, et al. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16.PubMedCentralCrossRefPubMed Forsetlund L, Eike MC, Gjerberg E, et al. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16.PubMedCentralCrossRefPubMed
29.
go back to reference Stuijt CC, Franssen EJ, Egberts AC, et al. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947–54.CrossRefPubMed Stuijt CC, Franssen EJ, Egberts AC, et al. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947–54.CrossRefPubMed
30.
go back to reference Patterson SM, Hughes CM, Crealey G, et al. An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc. 2010;58(1):44–53.CrossRefPubMed Patterson SM, Hughes CM, Crealey G, et al. An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc. 2010;58(1):44–53.CrossRefPubMed
31.
32.
go back to reference Kuperman GJ, Gibson RF. Computer physician order entry: benefits, costs and issues. Arch Intern Med. 2003;139:31–9. Kuperman GJ, Gibson RF. Computer physician order entry: benefits, costs and issues. Arch Intern Med. 2003;139:31–9.
33.
go back to reference Kaushal R, Shojania KG, Bates DW. Benefits of computerized physician order entry and clinical decision support systems on medication safety. Arch Intern Med. 2003;163:1409–16.CrossRefPubMed Kaushal R, Shojania KG, Bates DW. Benefits of computerized physician order entry and clinical decision support systems on medication safety. Arch Intern Med. 2003;163:1409–16.CrossRefPubMed
34.
go back to reference Mattison ML, Afonso KA, Ngo LH, et al. Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med. 2010;170(15):1331–6.PubMedCentralCrossRefPubMed Mattison ML, Afonso KA, Ngo LH, et al. Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med. 2010;170(15):1331–6.PubMedCentralCrossRefPubMed
35.
go back to reference Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701.CrossRefPubMed Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701.CrossRefPubMed
36.
go back to reference Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.CrossRefPubMed Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.CrossRefPubMed
37.
go back to reference Bain KT, Holmes HM, Beers MH, et al. Discontinuing medicines: a novel approach for revising the prescribing stage of the medicine use process. J Am Geriatr Soc. 2008;56(10):1946–52.PubMedCentralCrossRefPubMed Bain KT, Holmes HM, Beers MH, et al. Discontinuing medicines: a novel approach for revising the prescribing stage of the medicine use process. J Am Geriatr Soc. 2008;56(10):1946–52.PubMedCentralCrossRefPubMed
38.
go back to reference Muzina DJ. Discontinuing an antidepressant? Tapering tips to ease distressing symptoms. Curr Psych. 2010;9(3):51–61. Muzina DJ. Discontinuing an antidepressant? Tapering tips to ease distressing symptoms. Curr Psych. 2010;9(3):51–61.
39.
go back to reference Morin CM, Bastien C, Guay B, et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psych. 2004;161:332–42.CrossRef Morin CM, Bastien C, Guay B, et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psych. 2004;161:332–42.CrossRef
Metadata
Title
A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study
Authors
Luca Pasina
Alessandra Marengoni
Simona Ghibelli
Flavio Suardi
Codjo D. Djade
Alessandro Nobili
Carlotta Franchi
Gianbattista Guerrini
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 2/2016
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-015-0336-z

Other articles of this Issue 2/2016

Drugs & Aging 2/2016 Go to the issue